The Role of Lazertinib in Patients With EGFR-Variant Non-Small Cell Lung Cancer

被引：0
|
作者：
Cheng, Haiying [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Montefiore Einstein Comprehens Canc Ctr, Dept Med Oncol, 1695 Eastchester Rd,2nd Floor, New York, NY 10461 USA
来源：
JAMA ONCOLOGY | 2024年 / 10卷 / 10期
关键词：
D O I：
10.1001/jamaoncol.2024.2607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1352 / 1353
页数：2
相关论文
共 50 条
  • [1] Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial
    Hong, Min Hee
    Choi, Yoon Ji
    Ahn, Hee Kyung
    Lim, Sun Min
    Keam, Bhumsuk
    Kim, Dong-Wan
    Kim, Tae Min
    Youk, Jeonghwan
    Kim, Yu Jung
    Hwang, Shinwon
    Kim, Sangwoo
    Kim, Ju Won
    Kim, Hye Ryun
    Kang, Jin Hyoung
    JAMA ONCOLOGY, 2024, 10 (10) : 1342 - 1351
  • [2] Management of EGFR-Variant and ALK-Positive Non-Small Cell Lung Cancer Brain Metastasis
    Pike, Luke R. G.
    Yu, Helena
    Rusthoven, Chad G.
    JAMA ONCOLOGY, 2025,
  • [3] LAZERTINIB IS SAFE AND EFFECTIVE IN NON-SMALL CELL LUNG CANCER
    不详
    CANCER DISCOVERY, 2019, 9 (12) : 1645 - 1645
  • [4] Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non-Small Cell Lung Cancer
    Cheng, Wen-Chien
    Wang, Guosheng
    Mei, Qi
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02):
  • [5] Cardiac Safety Assessment of Lazertinib in Patients with EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer
    Haddish-Berhane, N.
    Cho, B. C.
    Ahn, M.
    Han, J.
    Kim, S.
    Lee, K. H.
    Cho, E. K.
    Mehta, J.
    Xie, J.
    Shreeve, S. M.
    Knoblauch, R. E.
    Freeman, J.
    Roshak, A.
    Jang, S. B.
    Lee, H.
    Kang, S.
    Kim, K. B.
    Oh, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S677 - S678
  • [6] EGFR variant III expression in Chinese patients with non-small cell lung cancer.
    Wang, Jie
    Duan, Jianchun
    Bai, Hua
    Yang, Lu
    An, Tongtong
    Wang, Zhijie
    Zhuo, Minglei
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
    Cho, B. C.
    Lee, S. -H.
    Han, J. -Y.
    Cho, E. K.
    Lee, J. -S.
    Lee, K. H.
    Curtin, J. C.
    Gao, G.
    Xie, J.
    Schnepp, R. W.
    Bauml, J. M.
    Knoblauch, R. E.
    Thayu, M.
    Kim, D. -W.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S126 - S126
  • [8] The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer
    Ray, Mandira
    Salgia, Ravi
    Vokes, Everett E.
    ONCOLOGIST, 2009, 14 (11): : 1116 - 1130
  • [9] Ivonescimab Plus Chemotherapy in Patients With EGFR Variant Non-Small Cell Lung Cancer-Reply
    Fang, Wenfeng
    Li, Wenting
    Zhang, Li
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025, 333 (02):
  • [10] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
12345